Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Related posts:
Higdon Outdoors Recalls Battery Packs on XS Series Motion Waterfowl Decoys and Replacement Battery P...
March 29, 2023Mammut Sports Group Recalls Alugator Ride 3.0 Hoe and Alugator Ride SE Avalanche Shovels Due to Risk...
April 5, 2023NewCosplay Children’s Sleepwear Recalled Due to Violation of Federal Flammability Standards and Burn...
April 19, 2023Views: 304